Molecular targets of epigenetic regulation and effectors of environmental influences

Toxicology and Applied Pharmacology

Volumn 245, Issue 3, 2010, Pages 378-393

  Choudhuri, Supratim ^a   Cui, Yue ^b   Klaassen, Curtis D ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

DNA; Drug metabolizing enzymes; Histone modifications; Methylation; MiRNA; Transporters ncRNA

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACYL COENZYME A OXIDASE; AGOUTI PROTEIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H2A; HISTONE H2AX; HISTONE H2B; HISTONE H3; HISTONE METHYLTRANSFERASE; JANUS KINASE 2; METHYL CPG BINDING PROTEIN 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN MLH1; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNTRANSLATED RNA;

ADENOSINE DIPHOSPHATE RIBOSYLATION; CANCER GROWTH; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HUMAN; NONHUMAN; NUTRITIONAL STATUS; PARENTAL BEHAVIOR; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

AGING; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; HUMANS; MALE; MATERNAL BEHAVIOR; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL STATUS; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

EID: 77953126448     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.03.022     Document Type: Review

References (115)

1. Aagaard-Tillery K.M., Grove K., Bishop J., Ke X., Fu Q., McKnight R., Lane R.H. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J. Mol. Endocrinol. 2008, 41:91-102.
2. Alnouti Y., Patrick J.S., Klaassen C.D. Tissue distribution and ontogeny of organic cation transporter in mice. Drug. Metab. Disp. 2006, 34:477-482.
3. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308:1466-1469.
4. Berger S. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
5. Bhaumik S.R., Smith E., Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 2007, 14:1008-1016.
6. Brown S.E., Szyf M. Dynamic epigenetic states of ribosomal RNA promoters during the cell cycle. Cell Cycle 2008, 7:382-390.
7. Burdge G.C., Slater-Jefferies J., Torrens C., Phillips E.S., Hanson M.A., Lillycrop K.A. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br. J. Nutr. 2007, 97:435-439.
8. Cai X., Cullen B.R. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007, 13:313-316.
9. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 2002, 99:15524-15529.
10. Callinan P.A., Feinberg A.P. The emerging science of epigenomics. Hum. Mol. Genet. 2006, 15:R95-R101.
11. Christensen B.C., Houseman E.A., Marsit C.J., Zheng S., Wrensch M.R., Wiemels J.L., Nelson H.H., Karagas M.R., Padbury J.F., Bueno R., Sugarbaker D.J., Yeh R.F., Wiencke J.K., Kelsey K.T. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009, 5:e1000602.
12. Choudhuri S. Epigenetic regulation of gene and genome expression. Genomics: fundamentals and applications 2009, 101-128. Informa Healthcare, NY, 2009. S. Choudhuri, D.B. Carlson (Eds.).
13. Choudhuri S. Lesser known relatives of miRNA. Biochim. Biophys. Res. Commun. 2009, 388:177-180.
14. Choudhuri, S., 2010. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology. J. Biochem. Mol. Toxicol. (Feb 8, Electronic publication ahead of print). http://doi:10.1002/jbt.20325.
15. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA 2005, 102:13944-13949.
16. Crews D., Gore A.C., Hsu T.S., Dangleben N.L., Spinetta M., Schallert T., Anway M.D., Skinner M.K. Transgenerational epigenetic imprints on mate preference. Proc. Natl Acad. Sci. USA 2007, 104:5942-5946.
17. Cross S.H., Meehan R.R., Nan X., Bird A. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat. Genet. 1997, 16:256-259.
18. Cui Y.J., Cheng X., Weaver Y.M., Klaassen C.D. Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab. Dispos. 2009, 37:203-210.
19. Dasso M. Emerging roles of the SUMO pathway in mitosis. Cell Div. 2008, 3:5.
20. Dawson M.A., Bannister A.J., Göttgens B., Foster S.D., Bartke T., Green A.R., Kouzarides T. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009, 461:819-822.
21. De Bustos C., Ramos E., Young J.M., Tran R.K., Menzel U., Langford C.F., Eichler E.E., Hsu L., Henikoff S., Dumanski J.P., Trask B.J. Tissue-specific variation in DNA methylation levels along human chromosome 1. Epigenetics Chromatin. 2009, 2:7.
22. Douet V., Heller M.B., Le Saux O. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem. Biophys. Res. Commun. 2007, 354:66-71.
23. Duhl D.M., Vrieling H., Miller K.A., Wolff G.L., Barsh G.S. Neomorphic agouti mutations in obese yellow mice. Nat. Genet. 1994, 8:59-65.
24. Duncan I.W. Transvection effects in Drosophila. Annu. Rev. Genet. 2002, 36:521-556.
25. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
26. Edwards T.M., Myers J.P. Environmental exposures and gene regulation in disease etiology. Environ. Health Perspect. 2007, 115:1264-1270.
27. Esteller M., Risques R.A., Toyota M., Capella G., Moreno V., Peinado M.A., Baylin S.B., Herman J.G. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res. 2001, 61:4689-4692.
28. Fazzari M.J., Greally J.M. Epigenomics: beyond CpG islands. Nat. Rev. Genet. 2004, 5:446-455.
29. Felsenfeld G. A brief history of epigenetics. Epigenetics 2007, 15-22. CSHL Press, Cold Spring Harbor, NY. C.D. Allis, T. Jenuwein, D. Reinberg (Eds.).
30. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., Selhub J. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl Acad. Sci. USA 2002, 99:5606-5611.
31. Fujishiro H., Okugaki S., Yasumitsu S., Enomoto S., Himeno S. Involvement of DNA hypermethylation in down-regulation of the zinc transporter ZIP8 in cadmium-resistant metallothionein-null cells. Toxicol. Appl. Pharmacol. 2009, 241:195-201.
32. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 2003, 278:4035-4040.
33. Galvão T.C., Thomas J.O. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Nucleic Acids Res. 2005, 33:6603-6609.
34. Garcia-Dominguez M., Reyes J.C. SUMO association with repressor complexes, emerging routes for transcriptional control. Biochim. Biophys. Acta 2009, 1789:451-459.
35. Hammons G.J., Yan-Sanders Y., Jin B., Blann E., Kadlubar F.F., Lyn-Cook B.D. Specific site methylation in the 5′-flanking region of CYP1A2 interindividual differences in human livers. Life Sci. 2001, 69:839-845.
36. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., Wang W., Weng Z., Green R.D., Crawford G.E., Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
37. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., Ching K.A., Antosiewicz-Bourget J.E., Liu H., Zhang X., Green R.D., Lobanenkov V.V., Stewart R., Thomson J.A., Crawford G.E., Kellis M., Ren B. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
38. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 1998, 18:6538-6547.
39. Hendrich B., Abbott C., McQueen H., Chambers D., Cross S., Bird A. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm. Genome 1999, 10:906-912.
40. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999, 401:301-304.
41. Henikoff S., Comai L. Trans-sensing effects: the ups and downs of being together. Cell 1998, 93:329-332.
42. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007, 22:91-103.
43. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., Baylin S.B. Incidence and functional consequences of hMLH1 promoter in colorectal carcinoma. Proc. Natl Acad. Sci. USA 1998, 95:6870-6875.
44. Hudder A., Novak R.F. miRNAs: effectors of environmental influences on gene expression and disease. Toxicol. Sci. 2008, 103:228-240.
45. Illingworth R.S., Bird A.P. CpG islands-'A rough guide'. FEBS Lett. 2009, 583:1713-1720.
46. Imai S., Kikuchi R., Kusuhara H., Yagi S., Shiota K., Sugiyama Y. Analysis of DNA methylation and histone modification profiles of liver-specific transporters. Mol. Pharmacol. 2009, 75:568-576.
47. Inawaka K., Kawabe M., Takahashi S., Doi Y., Tomigahara Y., Tarui H., Abe J., Kawamura S., Shirai T. Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations. Toxicol. Appl. Pharmacol. 2009, 237:178-187.
48. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
49. Issa J.P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 2004, 4:988-993.
50. Jin B., Park D.W., Nam K.W., Oh G.T., Lee Y.S., Ryu D.Y. CpG methylation of the mouse CYP1A2 promoter. Toxicol. Lett. 2004, 152:11-18.
51. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
52. Jones P.A., Liang G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 2009, 10:805-811.
53. Kangaspeska S., Stride B., Métivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
54. Keppler B.R., Archer T.K. Chromatin-modifying enzymes as therapeutic targets-Part 1. Expert Opin. Ther. Targets 2008, 12:1301-1312.
55. Keppler B.R., Archer T.K. Chromatin-modifying enzymes as therapeutic targets-Part 2. Expert Opin. Ther. Targets 2008, 12:1457-1467.
56. Kikuchi R., Kusuhara H., Hattori N., Shiota K., Kim I., Gonzalez F.J., Sugiyama Y. Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol. Pharmacol. 2006, 70:887-896.
57. Kim M.S., Kondo T., Takada I., Youn M.Y., Yamamoto Y., Takahashi S., Matsumoto T., Fujiyama S., Shirode Y., Yamaoka I., Kitagawa H., Takeyama K., Shibuya H., Ohtake F., Kato S. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.
58. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 1971, 68:820-823.
59. Lee J.T., Davidow L.S., Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat. Genet. 1999, 21:400-404.
60. m4 allele in Drosophila. Genetics 2006, 173:2403-2406.
61. Li E., Bird A.P. DNA methylation in mammals. Epigenetics 2007, 341-356. CSHL Press, Cold Spring Harbor, NY. C.D. Allis, T. Jenuwein, D. Reinberg (Eds.).
62. Li Y., Cui Y., Hart S.N., Klaassen C.D., Zhong X.B. Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol. Pharmacol. 2009, 75:1171-1179.
63. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr. 2005, 135:1382-1386.
64. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
65. Mancini-Dinardo D., Steele S.J., Levorse J.M., Ingram R.S., Tilghman S.M. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev. 2006, 20:1268-1282.
66. McGowan P.O., Sasaki A., Huang T.C., Unterberger A., Suderman M., Ernst C., Meaney M.J., Turecki G., Szyf M. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE 2008, 3:e2085.
67. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
68. Memili E., Hong Y.K., Kim D.H., Ontiveros S.D., Strauss W.M. Murine Xist RNA isoforms are different at their 3' ends: a role for differential polyadenylation. Gene 2001, 266:131-137.
69. Métivier R., Gallais R., Tiffoche C., Le Péron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., Benes V., Jeltsch A., Gannon F., Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
70. Morgan H.D., Sutherland H.G., Martin D.I., Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 1999, 23:314-318.
71. Morris J.R., Chen J.-L., Geyer P.K. Two modes of transvection: enhancer action in trans and bypass of a chromatin insulator in cis. Proc. Natl Acad. Sci. USA 1998, 95:10740-10745.
72. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
73. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
74. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., Tempst P., Reinberg D., Bird A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 1999, 23:58-61.
75. Nikitina T., Ghosh R.P., Horowitz-Scherer R.A., Hansen J.C., Grigoryev S.A., Woodcock C.L. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem. 2007, 282:28237-28245.
76. Nishigaki M., Aoyagi K., Danjoh I., Fukaya M., Yanagihara K., Sakamoto H., Yoshida T., Sasaki H. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 2005, 65:2115-2124.
77. Okano M., Xie S., Li E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 1998, 26:2536-2540.
78. Okino S.T., Pookot D., Li L.C., Zhao H., Urakami S., Shiina H., Igawa M., Dahiya R. Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res. 2006, 66:7420-7428.
79. Pan Y.Z., Gao W., Yu A.M. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab. Dispos. 2009, 37:2112-2117.
80. Pauler F.M., Barlow D.P. Imprinting mechanisms-it only takes two. Genes Dev. 2006, 20:1203-1206.
81. Pirotta V. Transvection and chromosomal trans-interaction effects. Biochim. Biophys. Acta 1999, 1424:M1-M8.
82. Rakyan V.K., Blewitt M.E., Druker R., Preis J.I., Whitelaw E. Metastable epialleles in mammals. Trends Genet. 2002, 18:348-351.
83. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA 2000, 97:5237-5242.
84. Reamon-Buettner S.M., Mutschler V., Borlak J. The next innovation cycle in toxicogenomics: environmental epigenetics. Mutat. Res. 2008, 659:158-165.
85. Reinberg D. Epigenetics: from phenomenon to field. Epigenetics 2007, 1-13. CSHL Press, Cold Spring Harbor, NY, 2007. C.D. Allis, T. Jenuwein, D. Reinberg (Eds.).
86. Riggs A.D., Martienssen R.A., Russo V.E.A. Introduction. Epigenetic mechanisms of gene regulation 1996, 1-4. CSHL Press, Cold Spring Harbor, NY. V.E.A. Russo (Ed.).
87. Rodriguez-Antona C., Gomez A., Karlgren M., Sim S.C., Ingelman-Sundberg M. Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum. Genet. 2010, 127:1-17.
88. Sawada N., Sakaki T., Kitanaka S., Kato S., Inouye K. Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur. J. Biochem. 2001, 268:6607-6615.
89. Schneider S., Kaufmann W., Buesen R., van Ravenzwaay B. Vinclozolin-the lack of a transgenerational effect after oral maternal exposure during organogenesis. Reprod. Toxicol. 2008, 25:352-360.
90. Schnekenburger M., Peng L., Puga A. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta 2007, 1769:569-578.
91. Schoenherr C.J., Levorse J.M., Tilghman S.M. CTCF maintains differential methylation at the Igf 2/H19 locus. Nat. Genet. 2003, 33:66-69.
92. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl Acad. Sci. USA 2003, 100:13225-13230.
93. Shah Y.M., Morimura K., Yang Q., Tanabe T., Takagi M., Gonzalez F.J. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol. 2007, 27:4238-4247.
94. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
95. Shen L., Ahuja N., Shen Y., Habib N.A., Toyota M., Rashid A., Issa J.P. DNA methylation and environmental exposures in human hepatocellular carcinoma. J. Natl. Cancer Inst. 2002, 94:755-761.
96. Skinner M.K., Anway M.D., Savenkova M.I., Gore A.C., Crews D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One 2008, 3:e3745.
97. Skinner M.K., Manikkam M., Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol. Metab. 2010, 21:214-222.
98. Sleutels F., Zwart R., Barlow D.P. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 2002, 415:810-813.
99. Smith I.M., Glazer C.A., Mithani S.K., Ochs M.F., Sun W., Bhan S., Vostrov A., Abdullaev Z., Lobanenkov V., Gray A., Liu C., Chang S.S., Ostrow K.L., Westra W.H., Begum S., Dhara M., Califano J. Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS ONE 2009, 4:e4961.
100. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
101. Straussman R., Nejman D., Roberts D., Steinfeld I., Blum B., Benvenisty N., Simon I., Yakhini Z., Cedar H. Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol. 2009, 16:564-571.
102. Toyota M., Issa J.P. CpG island methylator phenotypes in aging and cancer. Semin. Cancer Biol. 1999, 9:349-357.
103. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., Yokoi T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res. 2006, 66:9090-9098.
104. Vakoc C.R., Mandat S.A., Olenchock B.A., Blobel G.A. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol. Cell. 2005, 19:381-391.
105. Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., Baltissen M.P., Stunnenberg H.G., Mann M., Timmers H.T. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007, 131:58-69.
106. Vertegaal A.C., Andersen J.S., Ogg S.C., Hay R.T., Mann M., Lamond A.I. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics. 2006, 5:2298-2310.
107. Wade P.A. Methyl CpG-binding proteins and transcriptional repression. Bioessays 2001, 23:1131-1137.
108. Wakefield R.I., Smith B.O., Nan X., Free A., Soteriou A., Uhrin D., Bird A.P., Barlow P.N. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 1999, 291:1055-1065.
109. Watt P.M., Kumar R., Kees U.R. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia. Genes Chromosomes Cancer 2000, 29:371-377.
110. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
111. Wise T.L., Pravtcheva D.D. The undermethylated state of a CpG island region in igf2 transgenes is dependent on the H19 enhancers. Genomics 1999, 60:258-271.
112. Wutz A., Rasmussen T.P., Jaenisch R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat. Genet. 2002, 30:167-174.
113. Yoon J.H., Smith L.E., Feng Z., Tang M., Lee C.S., Pfeifer G.P. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res. 2001, 61:7110-7117.
114. Zhang B., Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect. 2009, 117:231-240.
115. Zhou H., Chen W.D., Qin X., Lee K., Liu L., Markowitz S.D., Gerson S.L. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene 2001, 20:6009-6017.